Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

p53 as a unique target of action of cisplatin in acute leukaemia cells

Journal of Cellular and Molecular Medicine(2022)10.1111/jcmm.17502Source: DataRank Database

p53 as a unique target of action of cisplatin in acute leukaemia cells is a research paper published in Journal of Cellular and Molecular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.08)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Paul B. Tchounwou ORCID,Sanjay Kumar ORCID

Live enrichment

PubMed:35946055 PMC:PMC9443951 OpenAlex:https://openalex.org/W4290989705

National Institutes of Health

Grant: U54MD015929

National Institutes of Health

Grant: 3U54MD015929-03S1

Strengthening the Biomedical Data Science Training Program at Jackson State University

FWCI

0.08

Citation Percentile

0.4%

Citation Trend

2022

goldLicense: cc-by

journalhttps://doi.org/10.1111/jcmm.17502

publisherhttps://doi.org/10.1111/jcmm.17502

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17502

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/jcmm.17502

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35946055

Fields of Study

Retinoids in leukemia and cellular processesCancer-related Molecular PathwaysAcute Myeloid Leukemia Research0301 basic medicine03 medical and health sciencesAnimalsAntineoplastic AgentsApoptosisArsenic TrioxideCisplatinFemaleHumansLeukemia, Myeloid, AcuteLeukemia, Promyelocytic, AcuteMiceOvarian NeoplasmsTumor Suppressor Protein p53

MeSH Terms

Arsenic TrioxideAnimalsAntineoplastic AgentsCisplatinFemaleHumansOvarian NeoplasmsLeukemia, Myeloid, AcuteLeukemia, Promyelocytic, AcuteTumor Suppressor Protein p53ApoptosisMice

Keywords

Cancer researchArsenic trioxideCisplatinAcute promyelocytic leukemiaBone marrowBiologyCell cultureRetinoic acidApoptosisChemotherapyImmunologyBiochemistryp53Acute Promyelocytic LeukaemiaCrispr-cas9Mdm2-daxx-hauspOvarian NeoplasmsAntineoplastic AgentsOriginal ArticlesLeukemia, Myeloid, AcuteMiceLeukemia, Promyelocytic, AcuteAnimalsHumansFemaleTumor Suppressor Protein p53

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being